Literature DB >> 3338315

Amiodarone pulmonary toxicity presenting as a solitary lung mass.

R Arnon1, I Raz, T Chajek-Shaul, N Berkman, S Fields, H Bar-On.   

Abstract

Following treatment with amiodarone, a patient developed weight loss, fatigue and severe myopathy, without respiratory symptoms. A solitary lung infiltrate, impaired thyroid and liver function tests, and leukocytosis were evident. Biopsies from the lung lesion, liver, and bone marrow revealed foam cells. All these signs and symptoms subsided following cessation of amiodarone therapy. It is demonstrated that amiodarone may induce a localized lung lesion rather than diffuse pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338315     DOI: 10.1378/chest.93.2.425

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge.

Authors:  I Azzam; N Tov; N Elias; J E Naschitz
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

2.  Amiodaronoma: an unusual form of amiodarone-induced pulmonary toxicity.

Authors:  Julie Jarand; Andrew Lee; Richard Leigh
Journal:  CMAJ       Date:  2007-05-08       Impact factor: 8.262

Review 3.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

4.  Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts.

Authors:  Yun-Ping Lim; Cheng-Li Lin; Yen-Ning Lin; Wei-Chih Ma; Wei-Cheng Chen; Dong-Zong Hung; Chia-Hung Kao
Journal:  PLoS One       Date:  2015-01-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.